Drugs / Saccharomyces Boulardii Oral Powder
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07139366 | Oct 2025 → Sep 2026 overdue | Helicobacter pylori infectious disease, dyspepsia, gastric cancer, gastritis +1 | Yongquan Shi | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Saccharomyces Boulardii Oral Powder | “Drug: Saccharomyces Boulardii Oral Powder” NCT07139366 ↗ |
| Route | Oral | “Saccharomyces Boulardii Oral Powder” NCT07139366 ↗ |